Neuroone Medical Technologies (NMTC) Assets Average (2011 - 2026)

Neuroone Medical Technologies (NMTC) has reported Assets Average for 15 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 9.96% year-over-year to $6.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (down 9.96% YoY), and the FY2025 full-year result was $8.1 million, up 19.96% from the prior year.
• Assets Average eased to $6.9 million in Q2 2026 per NMTC's latest filing, from $8.1 million in the prior quarter.
• Across five years, Assets Average topped out at $15.6 million in Q1 2022 and bottomed at $5.1 million in Q3 2024.
• Historically, Assets Average has averaged $8.4 million across 5 years, with a median of $7.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets Average tumbled 49.48% in 2023, then surged 110.11% in 2025.
• Over 5 years, Assets Average stood at $11.2 million in 2022, then tumbled by 38.09% to $7.0 million in 2023, then fell by 14.77% to $5.9 million in 2024, then surged by 63.2% to $9.7 million in 2025, then retreated by 28.96% to $6.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $6.9 million, $8.1 million, and $9.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.